Fig. 1. Entorhinal axonal projections in APP23 mice.a, PHAL-labeled projection from the medial entorhinal cortex to the middle molecular layer (MML;arrow) of the dentate gyrus (DG) in an 18-month-old nontransgenic control mouse. Minor projections were identified to CA3 and CA1 of the hippocampus and to the thalamus (TH). The same pattern was observed in young APP23 mice that lack amyloid plaque formation. b, PHAL-labeled projection in an 18-month-old APP23 mouse. Main termination pattern in the MML (arrow) is similar to that seen in the control mouse with the most notable difference being the hyperinnervation of the thalamus. Note the amyloid deposits (blue–gray reaction product) throughout the hippocampus, the thalamus, and within the alveus (ALV). c, d, High magnification of the inferior blade of DG from the control mouse shown in a, and APP23 mouse shown in b. Note the thickened PHAL-labeled axons (arrow) and ballooned, spheroidal axon terminals (arrowheads) in the vicinity of amyloid plaques. In the MML, amyloid plaques were completely engulfed by entorhinal dystrophic terminals, whereas outside of the main entorhinal termination zone only a subpopulation of dystrophic boutons were PHAL-labeled. e, High magnification of PHAL-labeled axons with the characteristic dystrophic terminals around an amyloid plaque in the stratum-lacunosum moleculare of CA3. Many PHAL-labeled axons appear normal until directly adjacent to the amyloid (arrow), then typically curve around the amyloid periphery, forming several small swellings followed by a large terminal balloon-shaped swelling that turns away from the plaque (arrowhead). GC, granule cell layer of the dentate gyrus; IML, inner molecular layer;OML, outer molecular layer. Scale bars:a, 300 μm; c, e, 25 μm; panels a and b, andc and d have the same magnification.